JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

IonQ’s quantum technologies are poised to reshape industries, and health care is one of the most promising frontiers.

CCN1 is a key factor for stabilizing brain circuits in adulthood, offering a therapeutic target for conditions, such as Alzheimer's and PTSD.

"Instead of just saying young women suffer from IBS, we wanted rigorous science explaining why," said co-senior author Holly Ingraham, PhD.

The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.

Lyophilization model can help optimize freeze-drying steps for continuous manufacturing processes, according to MIT researchers.

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.

A study of over four thousand rats shows gut microbiomes are shaped by both individual genes and the genes of social partners through shared microbes.